| 摘要 |
A method of inhibiting temporomandibular disorder in a human which comprises the administration to a human in need thereof of an effective amount of a compound of formula (I) wherein R<1> and R<3> are, independently, -H, -CH3, -CO(C1-C6 alkyl), or -COAr, where Ar is optionally substituted phenyl; R<3> is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof.
|
